Sechenov University Advanced Molecular Technology, LLC
Advanced Molecular Technology, LLC was established in October 2019 as a spin-off of I.M. Sechenov First Moscow State Medical University (Sechenov University).
The company has assembled a world-class scientific team to address major drug discovery bottlenecks in the post-genomic era.
The company will initially employ 10 plus top-notch scientists working under a highly experienced scientific leadership.
Projects that require a critical mass of resources will have support of the Institute of Translational Medicine of Sechenov University with more than 110 scientists and professionals with exclusive on-demand support of over 30 chemists with advanced degrees.
Our mission - bring your ideas to serve the humanity healthy life
Our goal is to discover medicines for diseases with high unmet medical need through involvement of multidisciplinary human resources on a global scale.
We strive to make the process of drug discovery and development socially meaninigful and economically significant.
Our team has created an effective process for involving people that aligns with modern technological advances.
Specifically, the company aims to assemble a portfolio of chemical assets for the pharmaceutical enterprise.
Yury Porozov, PhD Co-Founder CSO
Vladimir Trukhan, PhD Co-Founder CEO
Vadim Tarasov, PhD Co-Founder GR Director
Vladimir Prusakov Co-Founder Commercial Director
Scientific Advisory Board
Helgi Schioth, Prof. Uppsala University
Giancario Cravotto, Prof. Turin University
Andrey Svistunov, Prof. Sechenov University
Jeffry Newton, Prof. MIT